MRI detected extaprostatic extension (EPE) in prostate cancer : Do all T3a patients have the same outcomes?

© 2020 Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology..

MRI-detected T3a prostate cancer is a heterogeneous disease. This post-hoc analysis of a prospective trial found that patients with T3a disease presenting obliteration of the recto-prostatic angle, contact-asymmetry of neuro-vascular bundle and periprostatic fat invasion, may be at higher risk of biochemical failure and metastases.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:24

Enthalten in:

Clinical and translational radiation oncology - 24(2020) vom: 25. Sept., Seite 135-139

Sprache:

Englisch

Beteiligte Personen:

Gomez-Iturriaga, A [VerfasserIn]
Büchser, D [VerfasserIn]
Miguel, I San [VerfasserIn]
Marban, M [VerfasserIn]
Urresola, A [VerfasserIn]
Ezquerro, A [VerfasserIn]
Gil, A [VerfasserIn]
Suarez, F [VerfasserIn]
Gonzalez, A [VerfasserIn]
Mairata, E [VerfasserIn]
Martinez-Indart, L [VerfasserIn]
Cacicedo, J [VerfasserIn]
Couñago, F [VerfasserIn]
Mínguez, P [VerfasserIn]
Casquero, F [VerfasserIn]

Links:

Volltext

Themen:

Biochemical failure
Extraprostatic extension
Journal Article
Metastases
Multiparametric MRI
Prostate cancer
Radiotherapy

Anmerkungen:

Date Revised 28.09.2020

published: Electronic-eCollection

Citation Status PubMed-not-MEDLINE

doi:

10.1016/j.ctro.2020.08.002

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM314481052